SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: phoenix_rising who wrote (1426)8/12/2015 1:59:17 PM
From: Mirror Image  Read Replies (1) of 2026
 
Yeah, unfortunately that's information we are not privy to.

Would be nice to know. If I recall correctly the last ( or one of the last ) communications between this board and our previous I.R. department had him say that there was no conversion effect on royalties ( from a foreign currency to the U.S. dollar ). But I REALLY doubt that is correct. If indeed there is a currency exchange, the scenario you put forth could explain some of the volatility in the average royalty price.

Also - what Eico put forward. Spain is/was not included in the IMS data. That itself does not have an effect on the older Quarter #'s. Is it possible that other countries are not included in those IMS estimates also?
Which would lead me to one of my previous complaints. Couldn't they show us ACTUAL sales amounts for the older quarters ( assuming all the data in that graph are Estimates )? Some of the sales data are almost a year old.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News